{"id":25749,"date":"2025-08-04T07:00:57","date_gmt":"2025-08-04T06:00:57","guid":{"rendered":"https:\/\/www.cryoport.com\/le-developpement-des-medicaments-antiretroviraux-en-2025-promesses-pressions-et-passage-a-lechelle\/"},"modified":"2026-02-13T10:05:16","modified_gmt":"2026-02-13T15:05:16","slug":"le-developpement-des-medicaments-antiretroviraux-en-2025-promesses-pressions-et-passage-a-lechelle","status":"publish","type":"post","link":"https:\/\/www.cryoport.com\/fr\/le-developpement-des-medicaments-antiretroviraux-en-2025-promesses-pressions-et-passage-a-lechelle\/","title":{"rendered":"Le d\u00e9veloppement des m\u00e9dicaments antir\u00e9troviraux en 2025 : Promesses, pressions et passage \u00e0 l’\u00e9chelle"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"

Alors que le secteur des m\u00e9dicaments de th\u00e9rapie innovante (MTI) arrive \u00e0 mi-parcours de l’ann\u00e9e 2025, l’\u00e9lan scientifique ne manque pas. Les th\u00e9rapies r\u00e9volutionnaires bas\u00e9es sur le CRISPR font la une des journaux. L’acc\u00e8s des patients aux th\u00e9rapies cellulaires et g\u00e9niques s’\u00e9tend au-del\u00e0 des premiers march\u00e9s d’adoption. Enfin, l’\u00e9volution de l’environnement r\u00e9glementaire mondial cr\u00e9e lentement mais s\u00fbrement de nouvelles possibilit\u00e9s de commercialisation. Mais ces promesses s’accompagnent de pressions. <\/p>\n","protected":false},"author":38,"featured_media":19694,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"single-with-related.php","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[635],"tags":[679,601,654],"class_list":["post-25749","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-gestion-de-la-chaine-du-froid","tag-atmps","tag-gestion-de-la-chaine-dapprovisionnement-mondiale","tag-leurope"],"acf":[],"yoast_head":"\nLe d\u00e9veloppement des m\u00e9dicaments antir\u00e9troviraux en 2025 : Promesses, pressions et passage \u00e0 l'\u00e9chelle - Cryoport Systems<\/title>\n<meta name=\"description\" content=\"Alors que le secteur des m\u00e9dicaments de th\u00e9rapie innovante (MTI) arrive \u00e0 mi-parcours de l'ann\u00e9e 2025, l'\u00e9lan scientifique ne manque pas. Les th\u00e9rapies r\u00e9volutionnaires bas\u00e9es sur le CRISPR font la une des journaux. L'acc\u00e8s des patients aux th\u00e9rapies cellulaires et g\u00e9niques s'\u00e9tend au-del\u00e0 des premiers march\u00e9s d'adoption. Enfin, l'\u00e9volution de l'environnement r\u00e9glementaire mondial cr\u00e9e lentement mais s\u00fbrement de nouvelles possibilit\u00e9s de commercialisation. Mais ces promesses s'accompagnent de pressions.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cryoport.com\/fr\/le-developpement-des-medicaments-antiretroviraux-en-2025-promesses-pressions-et-passage-a-lechelle\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Le d\u00e9veloppement des m\u00e9dicaments antir\u00e9troviraux en 2025 : Promesses, pressions et passage \u00e0 l'\u00e9chelle - Cryoport Systems\" \/>\n<meta property=\"og:description\" content=\"Alors que le secteur des m\u00e9dicaments de th\u00e9rapie innovante (MTI) arrive \u00e0 mi-parcours de l'ann\u00e9e 2025, l'\u00e9lan scientifique ne manque pas. Les th\u00e9rapies r\u00e9volutionnaires bas\u00e9es sur le CRISPR font la une des journaux. L'acc\u00e8s des patients aux th\u00e9rapies cellulaires et g\u00e9niques s'\u00e9tend au-del\u00e0 des premiers march\u00e9s d'adoption. Enfin, l'\u00e9volution de l'environnement r\u00e9glementaire mondial cr\u00e9e lentement mais s\u00fbrement de nouvelles possibilit\u00e9s de commercialisation. Mais ces promesses s'accompagnent de pressions.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cryoport.com\/fr\/le-developpement-des-medicaments-antiretroviraux-en-2025-promesses-pressions-et-passage-a-lechelle\/\" \/>\n<meta property=\"og:site_name\" content=\"Cryoport Systems\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-04T06:00:57+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-13T15:05:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cryoport.com\/wp-content\/uploads\/2025\/07\/Podcast-1-of-7.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"628\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"smendez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@cryoport\" \/>\n<meta name=\"twitter:site\" content=\"@cryoport\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"smendez\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/le-developpement-des-medicaments-antiretroviraux-en-2025-promesses-pressions-et-passage-a-lechelle\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/le-developpement-des-medicaments-antiretroviraux-en-2025-promesses-pressions-et-passage-a-lechelle\\\/\"},\"author\":{\"name\":\"smendez\",\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/#\\\/schema\\\/person\\\/41e3344a83f354e30051a36b4e0a5f86\"},\"headline\":\"Le d\u00e9veloppement des m\u00e9dicaments antir\u00e9troviraux en 2025 : Promesses, pressions et passage \u00e0 l’\u00e9chelle\",\"datePublished\":\"2025-08-04T06:00:57+00:00\",\"dateModified\":\"2026-02-13T15:05:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/le-developpement-des-medicaments-antiretroviraux-en-2025-promesses-pressions-et-passage-a-lechelle\\\/\"},\"wordCount\":15,\"publisher\":{\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/le-developpement-des-medicaments-antiretroviraux-en-2025-promesses-pressions-et-passage-a-lechelle\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.cryoport.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/Podcast-1-of-7.png\",\"keywords\":[\"ATMPs\",\"Gestion de la cha\u00eene d'approvisionnement mondiale\",\"L'Europe\"],\"articleSection\":[\"Gestion de la cha\u00eene du froid\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/le-developpement-des-medicaments-antiretroviraux-en-2025-promesses-pressions-et-passage-a-lechelle\\\/\",\"url\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/le-developpement-des-medicaments-antiretroviraux-en-2025-promesses-pressions-et-passage-a-lechelle\\\/\",\"name\":\"Le d\u00e9veloppement des m\u00e9dicaments antir\u00e9troviraux en 2025 : Promesses, pressions et passage \u00e0 l'\u00e9chelle - Cryoport Systems\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/le-developpement-des-medicaments-antiretroviraux-en-2025-promesses-pressions-et-passage-a-lechelle\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/le-developpement-des-medicaments-antiretroviraux-en-2025-promesses-pressions-et-passage-a-lechelle\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.cryoport.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/Podcast-1-of-7.png\",\"datePublished\":\"2025-08-04T06:00:57+00:00\",\"dateModified\":\"2026-02-13T15:05:16+00:00\",\"description\":\"Alors que le secteur des m\u00e9dicaments de th\u00e9rapie innovante (MTI) arrive \u00e0 mi-parcours de l'ann\u00e9e 2025, l'\u00e9lan scientifique ne manque pas. Les th\u00e9rapies r\u00e9volutionnaires bas\u00e9es sur le CRISPR font la une des journaux. L'acc\u00e8s des patients aux th\u00e9rapies cellulaires et g\u00e9niques s'\u00e9tend au-del\u00e0 des premiers march\u00e9s d'adoption. Enfin, l'\u00e9volution de l'environnement r\u00e9glementaire mondial cr\u00e9e lentement mais s\u00fbrement de nouvelles possibilit\u00e9s de commercialisation. Mais ces promesses s'accompagnent de pressions.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/le-developpement-des-medicaments-antiretroviraux-en-2025-promesses-pressions-et-passage-a-lechelle\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/le-developpement-des-medicaments-antiretroviraux-en-2025-promesses-pressions-et-passage-a-lechelle\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/le-developpement-des-medicaments-antiretroviraux-en-2025-promesses-pressions-et-passage-a-lechelle\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.cryoport.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/Podcast-1-of-7.png\",\"contentUrl\":\"https:\\\/\\\/www.cryoport.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/Podcast-1-of-7.png\",\"width\":1200,\"height\":628},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/le-developpement-des-medicaments-antiretroviraux-en-2025-promesses-pressions-et-passage-a-lechelle\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/homepage\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Le d\u00e9veloppement des m\u00e9dicaments antir\u00e9troviraux en 2025 : Promesses, pressions et passage \u00e0 l’\u00e9chelle\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/\",\"name\":\"Cryoport Systems\",\"description\":\"Enabling the Future of Medicine\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/#organization\",\"name\":\"Cryoport Systems\",\"url\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.cryoport.com\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/systems-square.png\",\"contentUrl\":\"https:\\\/\\\/www.cryoport.com\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/systems-square.png\",\"width\":1200,\"height\":1200,\"caption\":\"Cryoport Systems\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/cryoport\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/856887\",\"https:\\\/\\\/www.youtube.com\\\/user\\\/CryoportVideo\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.cryoport.com\\\/fr\\\/#\\\/schema\\\/person\\\/41e3344a83f354e30051a36b4e0a5f86\",\"name\":\"smendez\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3ce9d56659c228959822d42e6e9146f3170fc590e93aa3adda9bb496df111835?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3ce9d56659c228959822d42e6e9146f3170fc590e93aa3adda9bb496df111835?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/3ce9d56659c228959822d42e6e9146f3170fc590e93aa3adda9bb496df111835?s=96&d=mm&r=g\",\"caption\":\"smendez\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Le d\u00e9veloppement des m\u00e9dicaments antir\u00e9troviraux en 2025 : Promesses, pressions et passage \u00e0 l'\u00e9chelle - Cryoport Systems","description":"Alors que le secteur des m\u00e9dicaments de th\u00e9rapie innovante (MTI) arrive \u00e0 mi-parcours de l'ann\u00e9e 2025, l'\u00e9lan scientifique ne manque pas. Les th\u00e9rapies r\u00e9volutionnaires bas\u00e9es sur le CRISPR font la une des journaux. L'acc\u00e8s des patients aux th\u00e9rapies cellulaires et g\u00e9niques s'\u00e9tend au-del\u00e0 des premiers march\u00e9s d'adoption. Enfin, l'\u00e9volution de l'environnement r\u00e9glementaire mondial cr\u00e9e lentement mais s\u00fbrement de nouvelles possibilit\u00e9s de commercialisation. Mais ces promesses s'accompagnent de pressions.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cryoport.com\/fr\/le-developpement-des-medicaments-antiretroviraux-en-2025-promesses-pressions-et-passage-a-lechelle\/","og_locale":"fr_FR","og_type":"article","og_title":"Le d\u00e9veloppement des m\u00e9dicaments antir\u00e9troviraux en 2025 : Promesses, pressions et passage \u00e0 l'\u00e9chelle - Cryoport Systems","og_description":"Alors que le secteur des m\u00e9dicaments de th\u00e9rapie innovante (MTI) arrive \u00e0 mi-parcours de l'ann\u00e9e 2025, l'\u00e9lan scientifique ne manque pas. Les th\u00e9rapies r\u00e9volutionnaires bas\u00e9es sur le CRISPR font la une des journaux. L'acc\u00e8s des patients aux th\u00e9rapies cellulaires et g\u00e9niques s'\u00e9tend au-del\u00e0 des premiers march\u00e9s d'adoption. Enfin, l'\u00e9volution de l'environnement r\u00e9glementaire mondial cr\u00e9e lentement mais s\u00fbrement de nouvelles possibilit\u00e9s de commercialisation. Mais ces promesses s'accompagnent de pressions.","og_url":"https:\/\/www.cryoport.com\/fr\/le-developpement-des-medicaments-antiretroviraux-en-2025-promesses-pressions-et-passage-a-lechelle\/","og_site_name":"Cryoport Systems","article_published_time":"2025-08-04T06:00:57+00:00","article_modified_time":"2026-02-13T15:05:16+00:00","og_image":[{"width":1200,"height":628,"url":"https:\/\/www.cryoport.com\/wp-content\/uploads\/2025\/07\/Podcast-1-of-7.png","type":"image\/png"}],"author":"smendez","twitter_card":"summary_large_image","twitter_creator":"@cryoport","twitter_site":"@cryoport","twitter_misc":{"\u00c9crit par":"smendez"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.cryoport.com\/fr\/le-developpement-des-medicaments-antiretroviraux-en-2025-promesses-pressions-et-passage-a-lechelle\/#article","isPartOf":{"@id":"https:\/\/www.cryoport.com\/fr\/le-developpement-des-medicaments-antiretroviraux-en-2025-promesses-pressions-et-passage-a-lechelle\/"},"author":{"name":"smendez","@id":"https:\/\/www.cryoport.com\/fr\/#\/schema\/person\/41e3344a83f354e30051a36b4e0a5f86"},"headline":"Le d\u00e9veloppement des m\u00e9dicaments antir\u00e9troviraux en 2025 : Promesses, pressions et passage \u00e0 l’\u00e9chelle","datePublished":"2025-08-04T06:00:57+00:00","dateModified":"2026-02-13T15:05:16+00:00","mainEntityOfPage":{"@id":"https:\/\/www.cryoport.com\/fr\/le-developpement-des-medicaments-antiretroviraux-en-2025-promesses-pressions-et-passage-a-lechelle\/"},"wordCount":15,"publisher":{"@id":"https:\/\/www.cryoport.com\/fr\/#organization"},"image":{"@id":"https:\/\/www.cryoport.com\/fr\/le-developpement-des-medicaments-antiretroviraux-en-2025-promesses-pressions-et-passage-a-lechelle\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cryoport.com\/wp-content\/uploads\/2025\/07\/Podcast-1-of-7.png","keywords":["ATMPs","Gestion de la cha\u00eene d'approvisionnement mondiale","L'Europe"],"articleSection":["Gestion de la cha\u00eene du froid"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.cryoport.com\/fr\/le-developpement-des-medicaments-antiretroviraux-en-2025-promesses-pressions-et-passage-a-lechelle\/","url":"https:\/\/www.cryoport.com\/fr\/le-developpement-des-medicaments-antiretroviraux-en-2025-promesses-pressions-et-passage-a-lechelle\/","name":"Le d\u00e9veloppement des m\u00e9dicaments antir\u00e9troviraux en 2025 : Promesses, pressions et passage \u00e0 l'\u00e9chelle - Cryoport Systems","isPartOf":{"@id":"https:\/\/www.cryoport.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cryoport.com\/fr\/le-developpement-des-medicaments-antiretroviraux-en-2025-promesses-pressions-et-passage-a-lechelle\/#primaryimage"},"image":{"@id":"https:\/\/www.cryoport.com\/fr\/le-developpement-des-medicaments-antiretroviraux-en-2025-promesses-pressions-et-passage-a-lechelle\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cryoport.com\/wp-content\/uploads\/2025\/07\/Podcast-1-of-7.png","datePublished":"2025-08-04T06:00:57+00:00","dateModified":"2026-02-13T15:05:16+00:00","description":"Alors que le secteur des m\u00e9dicaments de th\u00e9rapie innovante (MTI) arrive \u00e0 mi-parcours de l'ann\u00e9e 2025, l'\u00e9lan scientifique ne manque pas. Les th\u00e9rapies r\u00e9volutionnaires bas\u00e9es sur le CRISPR font la une des journaux. L'acc\u00e8s des patients aux th\u00e9rapies cellulaires et g\u00e9niques s'\u00e9tend au-del\u00e0 des premiers march\u00e9s d'adoption. Enfin, l'\u00e9volution de l'environnement r\u00e9glementaire mondial cr\u00e9e lentement mais s\u00fbrement de nouvelles possibilit\u00e9s de commercialisation. Mais ces promesses s'accompagnent de pressions.","breadcrumb":{"@id":"https:\/\/www.cryoport.com\/fr\/le-developpement-des-medicaments-antiretroviraux-en-2025-promesses-pressions-et-passage-a-lechelle\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cryoport.com\/fr\/le-developpement-des-medicaments-antiretroviraux-en-2025-promesses-pressions-et-passage-a-lechelle\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.cryoport.com\/fr\/le-developpement-des-medicaments-antiretroviraux-en-2025-promesses-pressions-et-passage-a-lechelle\/#primaryimage","url":"https:\/\/www.cryoport.com\/wp-content\/uploads\/2025\/07\/Podcast-1-of-7.png","contentUrl":"https:\/\/www.cryoport.com\/wp-content\/uploads\/2025\/07\/Podcast-1-of-7.png","width":1200,"height":628},{"@type":"BreadcrumbList","@id":"https:\/\/www.cryoport.com\/fr\/le-developpement-des-medicaments-antiretroviraux-en-2025-promesses-pressions-et-passage-a-lechelle\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cryoport.com\/fr\/homepage\/"},{"@type":"ListItem","position":2,"name":"Le d\u00e9veloppement des m\u00e9dicaments antir\u00e9troviraux en 2025 : Promesses, pressions et passage \u00e0 l’\u00e9chelle"}]},{"@type":"WebSite","@id":"https:\/\/www.cryoport.com\/fr\/#website","url":"https:\/\/www.cryoport.com\/fr\/","name":"Cryoport Systems","description":"Enabling the Future of Medicine","publisher":{"@id":"https:\/\/www.cryoport.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cryoport.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.cryoport.com\/fr\/#organization","name":"Cryoport Systems","url":"https:\/\/www.cryoport.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.cryoport.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.cryoport.com\/wp-content\/uploads\/2023\/12\/systems-square.png","contentUrl":"https:\/\/www.cryoport.com\/wp-content\/uploads\/2023\/12\/systems-square.png","width":1200,"height":1200,"caption":"Cryoport Systems"},"image":{"@id":"https:\/\/www.cryoport.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/cryoport","https:\/\/www.linkedin.com\/company\/856887","https:\/\/www.youtube.com\/user\/CryoportVideo"]},{"@type":"Person","@id":"https:\/\/www.cryoport.com\/fr\/#\/schema\/person\/41e3344a83f354e30051a36b4e0a5f86","name":"smendez","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/3ce9d56659c228959822d42e6e9146f3170fc590e93aa3adda9bb496df111835?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/3ce9d56659c228959822d42e6e9146f3170fc590e93aa3adda9bb496df111835?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/3ce9d56659c228959822d42e6e9146f3170fc590e93aa3adda9bb496df111835?s=96&d=mm&r=g","caption":"smendez"}}]}},"_links":{"self":[{"href":"https:\/\/www.cryoport.com\/fr\/wp-json\/wp\/v2\/posts\/25749","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cryoport.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cryoport.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cryoport.com\/fr\/wp-json\/wp\/v2\/users\/38"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cryoport.com\/fr\/wp-json\/wp\/v2\/comments?post=25749"}],"version-history":[{"count":1,"href":"https:\/\/www.cryoport.com\/fr\/wp-json\/wp\/v2\/posts\/25749\/revisions"}],"predecessor-version":[{"id":26448,"href":"https:\/\/www.cryoport.com\/fr\/wp-json\/wp\/v2\/posts\/25749\/revisions\/26448"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cryoport.com\/fr\/wp-json\/wp\/v2\/media\/19694"}],"wp:attachment":[{"href":"https:\/\/www.cryoport.com\/fr\/wp-json\/wp\/v2\/media?parent=25749"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cryoport.com\/fr\/wp-json\/wp\/v2\/categories?post=25749"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cryoport.com\/fr\/wp-json\/wp\/v2\/tags?post=25749"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}